AfricInvest Exits Polymedic to NBK Capital Partners

06 Jan 2020

AfricInvest, a leading pan-African private equity platform, is pleased to announce that its Maghreb Private Equity Fund III (MPEF III) has exited from its investment in Polymedic, a leading generics manufacturing company headquartered in Casablanca, Morocco, which owns a diverse portfolio of over 200 registered products across 12 therapeutic areas. NBK Capital Partners, an alternative investments firm that provides flexible growth capital to mid-sized companies in the Middle East, North Africa and Turkey has acquired AfricInvest’s stake.

NBK Capital Partners, alongside Foursan Capital Partners, an institutional private equity fund based in Amman, Jordan will now own majority stake in Polymedic, while Dr. Mohamed Houbachi, Polymedic CEO, will retain a significant stake. He will remain CEO of Polymedic and will partner with NBK Capital Partners and Foursan Group on the company’s next stage of growth.

Brahim El Jaï, Executive Partner at AfricInvest said, “We have been delighted to support Polymedic’s growth into a strong and sustainable business with best-in-class management and a clear vision for continued advancement. It has been both a pleasure and an honor to partner with Dr. Houbachi, whose prescience and entrepreneurial spirit have been essential components of the company’s success to date. We look forward to Polymedic’s bright future as it begins its new partnership with NBK Capital Partners.”

Yaser Moustafa, Senior Managing Director of NBK Capital Partners added, “This acquisition is very exciting for NBK Capital Partners, as it allows us to grow our presence in a sector that is buoyed by positive developments. Partnering with industry experts such as Dr. Houbachi who carry immense knowledge and experience in the pharmaceutical sector is a great opportunity for us and we look forward to continuing to drive growth through similar successful collaborations to increase our presence in Morocco and North Africa.”

Nashat Masri, Partner at Foursan, said, “The concept of aggregating pharmaceutical assets in various countries under a single investment platform has enormous synergistic potential, especially as regulatory environments across the region become increasingly sophisticated and as countries continue to move toward favouring their home industries.”

Dr. Mohamed Houbachi, CEO of Polymedic, added, “I am excited to partner with NBK Capital Partners and look forward to further growing and expanding the business in Morocco and West Africa. I am confident that being part of a regional platform will enable the business to further develop and leverage the tools available to us.”

-END-

« Back to Member News

AVCA FOCUS LIVE State of African Private Equity & Venture Capital: Regional Perspectives Thursday, 12th November 2… https://t.co/tW17gpsZn5

AVCA is delighted to launch its online training series. Join us on the first series, which will cover Fundraising,… https://t.co/hMf5s4mZiz

AVCA Member News: AIIM in Witkop Solar Park deal Read more: https://t.co/iOiXB8FoEm

According to our new report, North Africa attracted the largest share of PE deals by volume and value with 31% and… https://t.co/vuvCc0fTwK

AVCA partners with @forbesafrica on inaugural Private Equity supplement. “As the pan-African private equity and ve… https://t.co/sCox8j19Ja

;